Steffensen LH - Search Results

1

Vitamin D supplementation and systemic inflammation in relapsing-remitting multiple sclerosis.

Røsjø E, Steffensen LH, Jørgensen L, Lindstrøm JC, Šaltytė Benth J, Michelsen AE, Aukrust P, Ueland T, Kampman MT, Torkildsen Ø, Holmøy T. Røsjø E, et al. Among authors: steffensen lh. J Neurol. 2015 Dec;262(12):2713-21. doi: 10.1007/s00415-015-7902-5. Epub 2015 Oct 1. J Neurol. 2015. PMID: 26429571 Clinical Trial.

2

Comment on Shuhaibar et al.: Favourable effect of immunomodulator therapy on bone mineral density in multiple sclerosis.

Kampman MT, Steffensen LH. Kampman MT, et al. Among authors: steffensen lh. Ir J Med Sci. 2009 Jun;178(2):235-6; author reply 237-8. doi: 10.1007/s11845-009-0275-y. Epub 2009 Jan 31. Ir J Med Sci. 2009. PMID: 19184608 No abstract available.

3

Predictors and prevalence of low bone mineral density in fully ambulatory persons with multiple sclerosis.

Steffensen LH, Mellgren SI, Kampman MT. Steffensen LH, et al. J Neurol. 2010 Mar;257(3):410-8. doi: 10.1007/s00415-009-5337-6. Epub 2009 Oct 1. J Neurol. 2010. PMID: 19795152

4

The role of vitamin D in multiple sclerosis.

Kampman MT, Steffensen LH. Kampman MT, et al. Among authors: steffensen lh. J Photochem Photobiol B. 2010 Nov 3;101(2):137-41. doi: 10.1016/j.jphotobiol.2010.04.003. Epub 2010 Apr 21. J Photochem Photobiol B. 2010. PMID: 20471852 Review.

5

Can vitamin D supplementation prevent bone loss in persons with MS? A placebo-controlled trial.

Steffensen LH, Jørgensen L, Straume B, Mellgren SI, Kampman MT. Steffensen LH, et al. J Neurol. 2011 Sep;258(9):1624-31. doi: 10.1007/s00415-011-5980-6. Epub 2011 Mar 13. J Neurol. 2011. PMID: 21400196 Free PMC article. Clinical Trial.

6

Effect of vitamin D3 supplementation on relapses, disease progression, and measures of function in persons with multiple sclerosis: exploratory outcomes from a double-blind randomised controlled trial.

Kampman MT, Steffensen LH, Mellgren SI, Jørgensen L. Kampman MT, et al. Among authors: steffensen lh. Mult Scler. 2012 Aug;18(8):1144-51. doi: 10.1177/1352458511434607. Epub 2012 Feb 21. Mult Scler. 2012. PMID: 22354743 Clinical Trial.

7

What is needed to keep persons with multiple sclerosis vitamin D-sufficient throughout the year?

Steffensen LH, Brustad M, Kampman MT. Steffensen LH, et al. J Neurol. 2013 Jan;260(1):182-8. doi: 10.1007/s00415-012-6611-6. Epub 2012 Aug 1. J Neurol. 2013. PMID: 22850935 Clinical Trial.

8

Effect of high-dose vitamin D₃ supplementation on antibody responses against Epstein-Barr virus in relapsing-remitting multiple sclerosis.

Røsjø E, Lossius A, Abdelmagid N, Lindstrøm JC, Kampman MT, Jørgensen L, Sundström P, Olsson T, Steffensen LH, Torkildsen Ø, Holmøy T. Røsjø E, et al. Among authors: steffensen lh. Mult Scler. 2017 Mar;23(3):395-402. doi: 10.1177/1352458516654310. Epub 2016 Jul 11. Mult Scler. 2017. PMID: 27325604

9

High dose vitamin D supplementation does not affect biochemical bone markers in multiple sclerosis - a randomized controlled trial.

Holmøy T, Lindstrøm JC, Eriksen EF, Steffensen LH, Kampman MT. Holmøy T, et al. Among authors: steffensen lh. BMC Neurol. 2017 Apr 4;17(1):67. doi: 10.1186/s12883-017-0851-0. BMC Neurol. 2017. PMID: 28376767 Free PMC article. Clinical Trial.

10

Vitamin D supplementation and neurofilament light chain in multiple sclerosis.

Holmøy T, Røsjø E, Zetterberg H, Blennow K, Lindstrøm JC, Steffensen LH, Kampman MT. Holmøy T, et al. Among authors: steffensen lh. Acta Neurol Scand. 2019 Feb;139(2):172-176. doi: 10.1111/ane.13037. Epub 2018 Nov 12. Acta Neurol Scand. 2019. PMID: 30317548 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

21 results

Search Page